Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Boxenbaum

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
The American Journal of Psychiatry|November 1, 1985
Pharmacokinetic interaction of disulfiram and antidepressantsD A Ciraulo, J Barnhill, H Boxenbaum
Journal of Theoretical Biology|September 22, 1989
Gompertzian mortality derived from competition between cell-types: congenital, toxicologic and biometric determinants of longevityL Bass, H S Green, H Boxenbaum
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|August 22, 2000
Pharmacokinetics tricks and traps: drug dosage adjustment in renal failureH Boxenbaum, S Tannenbaum, M Mayersohn, et al.
Biopharmaceutics & Drug Disposition|March 1, 1993
Human dolasetron pharmacokinetics: II. Absorption and disposition following single-dose oral administration to normal male subjectsH Boxenbaum, T Gillespie, K Heck, et al.
Pharmaceutical Research|April 1, 1988
Quantitative structure-activity study on human pharmacokinetic parameters of benzodiazepines using the graph theoretical approachR S Markin, W J Murray, H Boxenbaum
Pharmaceutical Research|April 1, 1988
ABSPLOTS: a LOTUS 123 spreadsheet for calculating and plotting drug absorption ratesR C Shumaker, H Boxenbaum, G A Thompson
Biopharmaceutics & Drug Disposition|December 1, 1992
Human dolasetron pharmacokinetics: I. Disposition following single-dose intravenous administration to normal male subjectsH Boxenbaum, T Gillespie, K Heck, et al.
Drug Metabolism Reviews|January 1, 1988
Hormesis, Gompertz functions, and risk assessmentH Boxenbaum, P J Neafsey, D J Fournier
Drug Metabolism Reviews|January 1, 1985
Mortality kinetics in toxicology studiesH Boxenbaum, C B McCullough, F J Di Carlo
Drug Metabolism Reviews|January 1, 1988
A Gompertz age-specific mortality rate model of aging, hormesis, and toxicity: fixed-dose studiesP J Neafsey, H Boxenbaum, D A Ciraulo, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
The American Journal of Psychiatry|November 1, 1985
Pharmacokinetic interaction of disulfiram and antidepressantsD A Ciraulo, J Barnhill, H Boxenbaum
Journal of Theoretical Biology|September 22, 1989
Gompertzian mortality derived from competition between cell-types: congenital, toxicologic and biometric determinants of longevityL Bass, H S Green, H Boxenbaum
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|August 22, 2000
Pharmacokinetics tricks and traps: drug dosage adjustment in renal failureH Boxenbaum, S Tannenbaum, M Mayersohn, et al.
Biopharmaceutics & Drug Disposition|March 1, 1993
Human dolasetron pharmacokinetics: II. Absorption and disposition following single-dose oral administration to normal male subjectsH Boxenbaum, T Gillespie, K Heck, et al.
Pharmaceutical Research|April 1, 1988
Quantitative structure-activity study on human pharmacokinetic parameters of benzodiazepines using the graph theoretical approachR S Markin, W J Murray, H Boxenbaum
Pharmaceutical Research|April 1, 1988
ABSPLOTS: a LOTUS 123 spreadsheet for calculating and plotting drug absorption ratesR C Shumaker, H Boxenbaum, G A Thompson
Biopharmaceutics & Drug Disposition|December 1, 1992
Human dolasetron pharmacokinetics: I. Disposition following single-dose intravenous administration to normal male subjectsH Boxenbaum, T Gillespie, K Heck, et al.
Drug Metabolism Reviews|January 1, 1988
Hormesis, Gompertz functions, and risk assessmentH Boxenbaum, P J Neafsey, D J Fournier
Drug Metabolism Reviews|January 1, 1985
Mortality kinetics in toxicology studiesH Boxenbaum, C B McCullough, F J Di Carlo
Drug Metabolism Reviews|January 1, 1988
A Gompertz age-specific mortality rate model of aging, hormesis, and toxicity: fixed-dose studiesP J Neafsey, H Boxenbaum, D A Ciraulo, et al.
Pageof 5